theory clinical_46_6
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  Breaks :: "entity ⇒ bool"
  DoubleStrand :: "entity ⇒ bool"
  ReplicationAssociated :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  SingleStrand :: "entity ⇒ bool"
  Force :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"  (* Changed from entity to entity ⇒ bool *)
  Rely :: "event ⇒ bool"
  HomologousRecombination :: "event ⇒ bool"
  Defective :: "event ⇒ bool"
  NonHomologousEndJoining :: "event ⇒ bool"
  ErrorProne :: "event ⇒ bool"
  DNA :: "entity ⇒ bool"  (* Changed from entity to entity ⇒ bool *)
  SyntheticLethality :: "entity ⇒ bool"
  Occur :: "event ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  GeneticEvents :: "entity ⇒ bool"
  Multiple :: "entity ⇒ bool"
  LossOfPALB2 :: "entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Result :: "event ⇒ bool"
  CellDeath :: "entity ⇒ bool"  (* Changed from entity to entity ⇒ bool *)
  Mechanism :: "entity ⇒ bool"
  Singular :: "entity ⇒ bool"
  PARP1Inhibition :: "entity ⇒ bool"
  Combine :: "event ⇒ bool"
  Depend :: "event ⇒ bool"
  Inadequate :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  TherapeuticWindow :: "entity ⇒ bool"
  Create :: "event ⇒ bool"
  Patients :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Treatment :: "entity ⇒ bool"

(* Explanation 1: PARP inhibitors cause replication‐associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3 e4 e5. PARPInhibitors x ∧ Breaks y ∧ DoubleStrand y ∧ ReplicationAssociated y ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Repair e2 ∧ SingleStrand z ∧ Agent e2 x ∧ Patient e2 z ∧ Force e3 ∧ Agent e3 x ∧ Patient e3 c ∧ Cells c ∧ Rely e4 ∧ Agent e4 c ∧ Cells c ∧ Repair e5 ∧ HomologousRecombination e5 ∧ Defective e5 ∧ NonHomologousEndJoining e5 ∧ ErrorProne e5 ∧ Patient e5 d ∧ DNA d"

(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)
axiomatization where
  explanation_2: "∃x y z e1 e2 e3 e4. SyntheticLethality x ∧ Occur e1 ∧ Agent e1 x ∧ CoOccurrence y ∧ GeneticEvents y ∧ Multiple y ∧ LossOfPALB2 z ∧ In y z ∧ Result e2 ∧ Agent e2 y ∧ Patient e2 cd ∧ CellDeath cd ∧ Rely e3 ∧ Agent e3 c ∧ Cells c ∧ Mechanism w ∧ Singular w ∧ Repair e4 ∧ Agent e4 w ∧ Patient e4 d ∧ DNA d"

(* Explanation 3: The loss of PALB2 in cells can lead to synthetic lethality when combined with PARP1 inhibition, as it forces cells to depend on a singular, often inadequate, DNA repair mechanism, leading to cell death. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3 e4 e5. LossOfPALB2 x ∧ In x c ∧ Cells c ∧ SyntheticLethality y ∧ Lead e1 ∧ Agent e1 x ∧ Patient e1 y ∧ PARP1Inhibition z ∧ Combine e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Force e3 ∧ Agent e3 x ∧ Patient e3 c ∧ Cells c ∧ Depend e4 ∧ Agent e4 c ∧ Cells c ∧ Mechanism w ∧ Singular w ∧ Inadequate w ∧ Repair e5 ∧ Agent e5 w ∧ Patient e5 d ∧ DNA d ∧ Lead e6 ∧ Agent e6 w ∧ Patient e6 cd ∧ CellDeath cd"

(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3 e4 e5 e6. Cells x ∧ LossOfPALB2 y ∧ In x y ∧ Mechanism z ∧ Singular z ∧ Repair e1 ∧ Agent e1 z ∧ Patient e1 d ∧ DNA d ∧ Rely e2 ∧ Agent e2 x ∧ Patient e2 z ∧ PARP1Inhibition w ∧ DueTo e2 w ∧ TherapeuticWindow v ∧ Create e3 ∧ Agent e3 x ∧ Patient e3 v ∧ Patients u ∧ Benefit e4 ∧ Agent e4 u ∧ Treatment t ∧ Patient e4 t ∧ Mechanism z ∧ Inadequate z ∧ Lead e5 ∧ Agent e5 z ∧ Patient e5 cd ∧ CellDeath cd"

theorem hypothesis:
  assumes asm: "Patients x ∧ LossOfPALB2 y ∧ In x y ∧ PARP1Inhibition z"
  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)
  shows "∃x y z e1 e2 e3. Patients x ∧ LossOfPALB2 y ∧ In x y ∧ PARP1Inhibition z ∧ Benefit e1 ∧ Agent e1 x ∧ Patient e1 z ∧ SyntheticLethality e2 ∧ Cause e2 e3 ∧ Rely e3 ∧ Agent e3 c ∧ Cells c ∧ Mechanism w ∧ Singular w ∧ Repair e4 ∧ Agent e4 w ∧ Patient e4 d ∧ DNA d"
  sledgehammer
  oops

end
